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The enantiomers ofU50,488 (1, in fig. 1), ligands highly selective for x-opioid receptors, have been prepared 
by a refined procedure and their optical purity demonstrated. The absolute configuration of (+)-trans-2- 
pyrrolidinyl-N-methylcyclohexylamine, a ch mically versatile intermediate for synthesis of analogs of x- 
opioid receptor ligands with defined chirality, has been determined to be 1S,2S by X-ray crystallographic 
analysis. This intermediate has been used to synthesize the optically pure U50,488 enantiomers with known 
absolute configuration. 
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1. INTRODUCTION 
Many converging lines of pharmacological nd 
biochemical investigation have provided convinc- 
ing evidence for the existence of saturable, 
stereoselective and high-affinity/z-, 8- and x-opioid 
receptor subpopulations in the mammalian CNS 
[1]. Such studies have raised many questions con- 
cerning the structure and function of these sub- 
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types in the overall modulation of the CNS. A 
variety of structurally diverse opioid ligands have 
been required for demonstration of these subtypes 
and continue to be essential in defining receptor 
subtype function. In many cases, enantiomeric 
pairs of these ligands played a central role in detect- 
ing receptor mediated effects because of the high 
in vivo and i n vitro selectivity for one member of 
the optical pair. Such a recent striking example was 
the utilization of the narcotic antagonist ( - ) -  
naloxone and the pharmacologically inert (+)-  
isomer as tools for demonstration of opioid recep- 
tor occupancy by [tSF]cyclofoxy in the living ba- 
boon brain by positron emission tomography 
(PET) scanning [2]. 
Our previous studies of the /z- and ~-opioid 
receptors [3,4] have now been extended to include 
the x receptors. For our initial work, we selected 
U50,488 which is among the most selective ligands 
for the x-opioid receptor subtype. Since it is well 
known that drug enantiomers can show distinctly 
different and in some cases opposite ffects [5], it 
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is imperative to utilize enantiomers of known op- 
tical purity for receptor studies. In addition, 
knowledge of the absolute configuration of a 
molecule, and bond angles and bond lengths 
around chiral centers determined from X-ray 
crystallographic analysis, are essential for 
molecular modeling and other studies aimed at 
detection of commonalities between structurally 
diverse classes of drugs which act at a given recep- 
tor subtype. We have now developed a refined syn- 
thesis of the enantiomers of U50,488 previously 
described in the patent literature [6,7], and have 
demonstrated their optical purity and determined 
their absolute configuration by single crystal X-ray 
analysis. 
2. MATERIALS AND METHODS 
2.1. Chemical synthesis 
Melting points were determined on a Thomas 
Hoover capillary apparatus and are uncorrected. 
HPLC (high-performance liquid chromatography) 
was performed with a Gilson model 303 with a sol- 
vent mixer (model 811), and a Data Master (model 
620). Optical rotations were measured with a 
Perkin Elmer 241 MC polarimeter, and GC (gas 
chromatography) on a Hewlett-Packard 5880A in- 
strument, with an SE-30 capillary column. A 
Nicolet model R3M automatic X-ray diffrac- 
tometer in 020 collection mode was used for X-ray 
crystallography [8]. All new compounds gave com- 
bustion analyses for carbon, hydrogen and 
nitrogen within _+ 0.4070 of the calculated value 
and were performed by Atlantic Microlabs, Atlan- 
ta, GA. Each compound gave mass, NMR (nuclear 
magnetic resonance), and IR (infrared) spectra 
consistent with their assigned structure. TLC 
system A refers to Analtech silica gel (GF) plates, 
eluting with a mixture of chloroform/methanol/  
conc. NHaOH (80: 18 : 2) and system B refers to the 
same system with a ratio of 90:9: 1. 
2.2. ( _+ )-trans-2-Pyrrolidinyl-N-methylcyclo- 
hexylamine [(_+)-2] 
Trifluoromethanesulfonic a id (4.9 ml, 0.1 
equiv.) was added dropwise (with caution) to a 
stirred mixture of N-methylcyclohexaneaziridine 
[6,9,10] (62.0 g, 0.56 mol), and pyrrolidine 
(280 ml, 6 equiv.) at - 10°C, and the solution was 
refluxed overnight under argon. Removal of excess 
pyrrolidine gave a two phase oily residue. The up- 
per phase with product 2 was removed, and the 
lower phase was dissolved in water (100 ml), 20070 
KOH solution was added, and the mixture was 
ether extracted (4 x 100 ml). The ethereal solution 
was dried (KOH pellets), and the ether emoved by 
distillation to give additional 2 which, combined 
with the upper phase, was fractionally distilled 
(b.p. 76-80°C/1.2 mm, in [10] b.p. 118- 
119°C/13 ram) to yield 94.8 g (93070) of 2 as a pure 
(by GC and TLC system A), clear colorless liquid. 
Treatment of 2 with HC1 gas in isopropanol af- 
forded a crystalline dihydrochloride hemihydrate 
salt: m.p. 242-243°C. 
2.3. (1S,2S)-( + )-trans-2-Pyrrolidinyl-N-methyl- 
cyclohexylamine [(+)-2] 
Initial resolution of (_+)-2 was carried out on a 
small scale by recrystallization (6 x ,  isopropa- 
nol/ether) of the 2:1 salts of (_+)-2 and (+)-  
or (-)-camphor-10-sulfonic a id to give 99070 
diastereomerically pure salts: m.p. 188-190°C. 
Conversion of each of the salts to their free base 
(with NH4OH), was followed by formation of their 
mandelate salt, on a small scale. These salts were 
used to seed the large scale preparation. In a large 
scale preparation, ethyl acetate (900 ml) was added 
to a solution of ( _+ )-2 (80.22 g, 440 mmol) and (S)- 
(+)-mandelic acid (66.95 g, 440 mmol) in 
methanol (300 ml). Crystallization occurred after 
distillation of the methanol from the solution, 
while maintaining a constant volume of 900 ml (by 
addition of ethyl acetate), and addition of a seed 
crystal. The crystals from the cooled mixture were 
washed twice with cold (0°C) ethyl acetate; 
recrystallization (3 x ,  ethyl acetate) afforded 
66.3g (90070) of (+)-2. (+)-Mandelate: m.p. 
168-169°C; [ad 23 + 106.4 ° (c 0.33, MeOH). The 
optical purity of (+)-2 base (b.p. 72°C/0.7 mm; 
[tz] 23 + 97.6 ° (c 0.29, MeOH)) was determined to 
be >99.5070 (vide infra). (+)-2.  HCI. ½H20: m.p. 
245-246°C, [cr] 23 +27.5 ° (c 0.276, MeOH); in [61 
m.p. 247.5-248.5°C, [or] 22 + 30 ° (c 0.97, CHC13). 
2.4. (1R,2R)-(- )-trans-2-Pyrrolidinyl-N-methyl- 
cyclohexylamine [(-)-2] 
Solvent was removed from the combined mother 
liquors of the (+)-2. (+)-Mandelate salt (vide 
supra), water (300 ml) was added to the crystalline 
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residue, and the mixture rendered strongly alkaline 
with 30070 aqueous NaOH (300 ml). Extraction 
with ether, drying (Na2SO4), and fractional 
distillation gave 40.1 g (91070 recovery) of the 
mixed bases. The mixed bases were dissolved in 
MeOH (150 ml), R-(-)-mandelic acid (33.5 g, 1 
equiv.) added, followed by ethyl acetate (900 ml). 
Distillation, crystallization (induced by a seed 
crystal), and recrystallization as above, gave 61.8 g 
(84070) of mandelate salt: m.p. 168-169°C; [or] z3 
- 105.9 ° (c 0.35, MeOH). The base was generated 
as above for the (+)-isomer: b.p. 72°C/0.7 mm; 
[cr]~ -97.4 ° (c 0.71, MeOH) (>99.5070 optically 
pure, as determined below). ( - ) -2 .HCI .  ½H20: 
m.p. 246-246.5°C, [od z3 -28.2 ° (c 0.28, MeOH); 
in [6] m.p. 240-242°C; [cr]zo 3 -28  ° (c 0.8, CHCID. 
2.5. Optically pure (R)-oe-methylbenzylisocyanate 
A solution of (-)-tartaric acid (150.09 g, 1 mol) 
in DMF (1 1) was treated with 121.18 g (1 mol) of 
commercial (+)<r-methylbenzylamine thathad a 
3.8°70 optical impurity. After crystallization of the 
salt was complete (cooling to 20°C), the salt was 
filtered and washed thoroughly with DMF (3 × 
500 ml), then thoroughly with ether (3 × 500 ml). 
The dried (in vacuo, 50°C) salt (220.1 g) was 
dissolved in DMF (660 ml, 120°C), and crystal- 
lized when cooled. It was filtered, pressed well, 
washed with ether (2 × 500 ml), and dried (in 
vacuo, 50°C) to give 180.25 g of product. Twice 
crystallized salt (175.0 g, 0.65 mol) was converted 
to the free base by addition of a cold solution of 
NaOH (102 g, in 600 ml of water). The base was 
washed with ether (200 ml, 100 ml), dried with 
MgSO4 (3 g), filtered and distilled (b.p. 83-85°C/ 
23 mm) to give ( + )<r-methylbenzylamine 
(70.91 g). Redistillation gave the chemically and 
optically (by HPLC analysis of the ureas, below) 
pure free base (69.9 g): [~,]24 + 39.3 ° (neat, d = 
0.9528). For determination of the enantiomeric 
purity of (+)-2 and ( - ) -2,  the isocyanate was 
prepared. A rapidly stirred solution of (+)-~- 
methylbenzylamine (6.0 g), rendered acidic with 
HCI gas, was treated ropwise at reflux with 25 ml 
of a 2007o solution of phosgene in toluene. When 
the solution became homogeneous, it was distilled 
to yield the isocyanate (5.29g, 73070): b.p. 
55°C/0.35 mm; [oe]~ 3 +9.83°; (neat, d = 1.0428) 
(in [11] [od~ 9 +9.6°; (neat, d = 1.0428)). 
2.6. Determination of the optical purity of (+)-2 
and (-)-2 
(R)-( + )-Methylbenzylisocyanate (1.2 equiv.) 
was added (under nitrogen, via syringe) to a stirred 
solution of (+)-2 or ( - ) -2  (10 mg, 0.055 mmol) in 
pentene stabilized chloroform (1 ml). The reaction 
was complete (by TLC, system A) after 10 min at 
room temperature. The respective diastereomeric 
ureas 3 and 4 (fig.l) were analyzed by HPLC on a 
20 cm Waters /~-Porasil analytical column with 
0.4" 3.6 : 96 ammonia/methanol/chloroform as 
eluant (UV detection at 254 nm). The HPLC 
analysis howed >99.5°70 diastereoisomeric purity 
of 3 and 4, indicating-similar optical purity of 
( + )-2 and ( - )-2. 
2.7. (1S,2S)-trans-3, 4-Dichloro-N-methyi-N-[2- 
(1-pyrrolidinyl) cyclohexyl-1]-benzene- 
acetamide [(-)-1] 
A solution of 3,4-dichlorophenylacetylchloride 
(2.94 g, 1.2 equiv.) in pentene stabilized 
chloroform (10 ml) was added to a rapidly stirred 
mixture of (+)-2 (2.00 g, 11.0 mmol) in pentene 
stabilized chloroform (40 ml) and NaHCO3 
(saturated solution, 25 ml). After 15 min, TLC 
system B indicated that the reaction was complete. 
The organic phase was washed with water (50 ml) 
and dried (Na2SO4) to give a yellow oil. Citric acid 
was added (2 equiv., based on the theoretical quan- 
tity of product), followed by water (200 ml) and 
ether (200 ml), and the mixture shaken until 
homogeneous. The aqueous layer was extracted 
with ether (2 × 100ml), and basified (conc. 
NH4OH). Extraction with chloroform (3 x 
100 ml) and drying through a plug of NazSO4 af- 
forded 3.75 g of ( - ) -1 as an oil. Addition of 
l-tartaric acid (1.48 g, 1 equiv.) gave the tartrate 
salt. Crystallization from H20/isopropanol (1: 19) 
gave the 1-tartrate.monohydrate of ( - ) - l  
(4.99 g): m.p. 153-154°C; [or] z3 -35.2 ° (c 0.28, 
MeOH). The HCI salt of ( - ) -1 crystallized from 
2 M HCI as a monohydrate: m.p. 91-94°C, [cr]zo 3 
-32 .9  ° (c 0.34, MeOH). 
2.8. (1R,2R)-trazls-3, 4-Dichloro-N-methyLN-[2- 
(1-pyrrolidin yl) cyclohexyl- 1]-benzene- 
acetamide [(+ )-1] 
The base ( - ) -2  (2.00 g, 11.0 mmol), was con- 
verted to the d-tartrate- monohydrate salt of ( + )-1 
(4.56 g), using the procedure described for ( - ) -1:  
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m.p. 155-156°C; [a']~) 3 +36.9 ° (c 0.22; MeOH). 
The HCI salt of (+)-1 crystallized from 2 M HCI 
as a monohydrate: m.p. 91-94°C, [oe] 23 + 31.8 ° (c 
0.31, MeOH). 
2.9. X-ray analysis 
The (R)-( -) -mandelate (1:1) salt of (+)-2 
crystallized in the triclinic space group P 1 with two 
Ct2H23N~.CsH70~ 'formula units' in the asym- 
metric unit. Cell dimensions are: a = 8.955(3), b = 
9.782(2), c = 11.968(3)A, te = 85.56(2), fl = 
71.30(2) and r = 69.82(2) °. Vol. = 931.3(5)A 3, 
dcal¢ = 1.193 g/cm 3, A(Mo Ko~) = 0.71069 A,/z = 
0.46 mm-1 and T = 225 K. The final R values are 
R = 0.049, and wR = 0.051 for the 2922 indepen- 
dent observed reflections. The goodness of fit 
parameter was 1.498 and the difference map was 
featureless. 
3. RESULTS AND DISCUSSION 
We have developed an efficient route to the op- 
tically pure enantiomers of U50,488 which make 
them available in quantity for various phar- 
macological studies. The route proceeds through a 
facile optical resolution of (+_)-2 to afford the 
enantiomeric intermediates (+)-2 and ( - ) -2  
(fig. 1). The absolute configurations of the U50,488 
c,6o, T ~ C(2a)  
:(3a} 
Fig.2. X-ray structure of (IS,2S)-(+)-trans-2-pyrrolidi- 
nyl-N-methylcyclohexylamine cation drawn from experi- 
mentally determined coordinates. The mandelate anion 
and the other crystallographically unique formulae units 
are omitted. The dashed lines are hydrogen bonds to 
mandelate anions. 
enantiomers, which follow from the absolute con- 
figuration of the enantiomer (+)-2 (1S,2S, based 
on the known configurations of (R)-( - )-mandelic 
acid), will undoubtedly be of considerable value in 
establishing structure-activity relationships with 
© © 
_CH 3 "- - 
1 ! 1 
(+)-1 (-)-1 (+)-1 
© 
QHCH 3 
(±) -2  
. Q cN. 
HCH3 
(+) -2  ( - ) -2  cs3 
3 4 
Fig.l. Structures of compounds. 
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other classes of ligands which interact with x- 
opioid receptors. Fig.2 shows the result [8] of the 
X-ray analysis for the cation (+)-2. There are two 
intermolecular hydrogen bonds between the cation 
and mandelate anions with the amine nitrogens ac- 
ting as donors to the mandelate oxygens. Inter- 
molecular hydrogen bonding also occurs between 
the mandelate anions. The determination of the 
absolute configuration of the chemically versatile 
intermediate (+)-2 (and, of course, ( - ) -2 )  allows 
the future synthesis of a host of different analogs 
of U50,488 which will have known absolute con- 
figuration at two centers of asymmetry. This will 
permit qualitative and quantitative r search on the 
relationship of the structure of analogs of U50,488 
to their experimentally determined activity on 
opioid receptor subtypes. 
NOTE ADDED IN PROOF 
Initial binding experiments using [3H]brema- 
zocine to label a x-opioid receptor of guinea pig 
brain demostrated that ( - )-1 and ( ÷ )-1 interacted 
with dissociation constants (Kd) of 124 and 90 300 
nM, respectively (Rothman, R.B. et al., in pre- 
paration). 
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